454 related articles for article (PubMed ID: 34335981)
1. Endothelial cell infection and dysfunction, immune activation in severe COVID-19.
Qin Z; Liu F; Blair R; Wang C; Yang H; Mudd J; Currey JM; Iwanaga N; He J; Mi R; Han K; Midkiff CC; Alam MA; Aktas BH; Heide RSV; Veazey R; Piedimonte G; Maness NJ; Ergün S; Mauvais-Jarvis F; Rappaport J; Kolls JK; Qin X
Theranostics; 2021; 11(16):8076-8091. PubMed ID: 34335981
[No Abstract] [Full Text] [Related]
2. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
3. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
4. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
[TBL] [Abstract][Full Text] [Related]
5. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
6. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Infects Endothelial Cells
Liu F; Han K; Blair R; Kenst K; Qin Z; Upcin B; Wörsdörfer P; Midkiff CC; Mudd J; Belyaeva E; Milligan NS; Rorison TD; Wagner N; Bodem J; Dölken L; Aktas BH; Vander Heide RS; Yin XM; Kolls JK; Roy CJ; Rappaport J; Ergün S; Qin X
Front Cell Infect Microbiol; 2021; 11():701278. PubMed ID: 34307198
[TBL] [Abstract][Full Text] [Related]
8. Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection.
Subramaniam S; Kenney D; Jayaraman A; O'Connell AK; Walachowski S; Montanaro P; Reinhardt C; Colucci G; Crossland NA; Douam F; Bosmann M
Front Immunol; 2024; 15():1397990. PubMed ID: 38911865
[TBL] [Abstract][Full Text] [Related]
9. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
10. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
11. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
Condor Capcha JM; Kamiar A; Robleto E; Saad AG; Cui T; Wong A; Villano J; Zhong W; Pekosz A; Medina E; Cai R; Sha W; Ranek MJ; Webster KA; Schally AV; Jackson RM; Shehadeh LA
Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2308342120. PubMed ID: 37983492
[TBL] [Abstract][Full Text] [Related]
16. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
17. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
Choi S; Lee J; Kim S; Lee YW; Kim GC; Hong SM; An SH; Noh H; Kim KE; On D; Lee SG; Jang HJ; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Kim DJ; Yoon JH; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Park JW; Yun JW; Shin JS; Seo JY; Nam KT; Choi KS; Kwon HK; Lee HY; Kim JK; Seong JK
EBioMedicine; 2024 Jan; 99():104932. PubMed ID: 38118400
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
[TBL] [Abstract][Full Text] [Related]
20. The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner.
Gupte SA; Bakshi CS; Blackham E; Duhamel GE; Jordan A; Salgame P; D'silva M; Khan MY; Nadler J; Gupte R
Br J Pharmacol; 2023 Oct; 180(20):2677-2693. PubMed ID: 37259182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
